GlaxoSmithKline Intellectual Property Development Limited
发明人:
Ding, Xiao,Liu, Qian,Sang, Yingxia,Stasi, Luigi Piero,Wan, Zehong,Zhao, Baowei,Edge, Colin Michael
申请号：
AU2018200277
公开号：
AU2018200277B2
申请日:
2018.01.12
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
#$%^&*AU2018200277B220190926.pdf#####H: rbr Interwovn NRPortbl DCC RBR 6286510_l.doex-12/01/2018 ABSTRACT COMPOUNDS 5 The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of or prevention of diseases characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).
